World Health Organization. World Malaria Report 2022. World Health Organization, Geneva (2023).

RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31–45 (2015).

Article  Google Scholar 

Datoo, M. S. et al. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. Lancet 397, 1809–1818 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Datoo, M. S. et al. Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years’ follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. Lancet Infect. Dis. 22, 1728–1736 (2022).

Article  CAS  PubMed  Google Scholar 

Datoo, M. S. et al. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. Lancet 403, 533–544 (2024).

Article  CAS  PubMed  Google Scholar 

Yadav, N. et al. More time to kill: A longer liver stage increases T cell-mediated protection against pre-erythrocytic malaria. iScience 26, 108489 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schofield, L. et al. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664–666 (1987).

Article  CAS  PubMed  Google Scholar 

Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H. & Good, M. F. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl Acad. Sci USA 85, 573–576 (1988).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weiss, W. R. & Jiang, C. G. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PLoS One 7, e31247 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yadav, N., Parmar, R., Patel, H., Patidar, M. & Dalai, S. K. Infectious sporozoite challenge modulates radiation attenuated sporozoite vaccine-induced memory CD8(+) T cells for better survival characteristics. Microbiol. Immunol. 66, 41–51 (2022).

Article  CAS  PubMed  Google Scholar 

Patel, H. et al. Parasite load stemming from immunization route determines the duration of liver-stage immunity. Parasite Immunol. 41, e12622 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Patel, H. et al. Frequent inoculations with radiation attenuated sporozoite is essential for inducing sterile protection that correlates with a threshold level of Plasmodia liver-stage specific CD8(+) T cells. Cell Immunol. 317, 48–54 (2017).

Article  CAS  PubMed  Google Scholar 

Lyke, K. E. et al. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc. Natl Acad. Sci. USA 114, 2711–2716 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roestenberg, M. et al. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 361, 468–477 (2009).

Article  CAS  PubMed  Google Scholar 

Roestenberg, M. et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377, 1770–1776 (2011).

Article  CAS  PubMed  Google Scholar 

Hoffman, S. L. et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185, 1155–1164 (2002).

Article  PubMed  Google Scholar 

Seder, R. A. et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359–1365 (2013).

Article  CAS  PubMed  Google Scholar 

Fernandez-Ruiz, D. et al. Liver-resident memory CD8(+) T cells form a front-line defense against malaria liver-stage infection. Immunity 45, 889–902 (2016).

Article  CAS  PubMed  Google Scholar 

Epstein, J. E. et al. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 334, 475–480 (2011).

Article  CAS  PubMed  Google Scholar 

Ewer, K. J. et al. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nat. Commun. 4, 2836 (2013).

Article  PubMed  Google Scholar 

Ishizuka, A. S. et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat. Med. 22, 614–623 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mordmuller, B. et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature 542, 445–449 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Nussenzweig, R. S., Vanderberg, J., Most, H. & Orton, C. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 216, 160–162 (1967).

Article  CAS  PubMed  Google Scholar 

Dodoo, D. et al. Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults. Malar. J. 10, 168 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Gwadz, R. W., Cochrane, A. H., Nussenzweig, V. & Nussenzweig, R. S. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull. World Health Org. 57, 165–173 (1979).

PubMed  PubMed Central  Google Scholar 

Clyde, D. F., Most, H., McCarthy, V. C. & Vanderberg, J. P. Immunization of man against sporozite-induced falciparum malaria. Am. J. Med Sci. 266, 169–177 (1973).

Article  CAS  PubMed  Google Scholar 

Ouattara, A. et al. An in silico analysis of malaria pre-erythrocytic-stage antigens interpreting worldwide genetic data to suggest vaccine candidate variants and epitopes. Microorganisms 10, https://doi.org/10.3390/microorganisms10061090 (2022).

Tucker, K. D. et al. Identification, selection and immune assessment of liver stage CD8 T cell epitopes from Plasmodium falciparum. Front. Immunol. 12, 684116 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Arredondo, S. A. et al. The micronemal Plasmodium Proteins P36 and P52 act in concert to establish the replication-permissive compartment within infected hepatocytes. Front. Cell Infect. Microbiol 8, 413 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

VanBuskirk, K. M. et al. Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc. Natl Acad. Sci. USA 106, 13004–13009 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Schaijk, B. C. et al. Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes. PloS One 3, e3549 (2008).

Article  PubMed  PubMed Central  Google Scholar 

Ishino, T., Chinzei, Y. & Yuda, M. Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte. Mol. Microbiol 58, 1264–1275 (2005).

Article  CAS  PubMed  Google Scholar 

Garzon-Ospina, D., Buitrago, S. P., Ramos, A. E. & Patarroyo, M. A. Identifying potential Plasmodium vivax Sporozoite Stage va